In line with this, scDb-scFv showed an approximately 100-fold reduced T-cell mediated killing of low HER3-expressing tumor cells (FaDu: ~ 3000 HER3/cell) compared to intermediate HER3-expressing tumor cells (MCF-7: ~ 18,000 HER3/cell). Here, ERBB3 is linked to neoplasm.